论文部分内容阅读
目的:探讨微生态制剂妈咪爱治疗新生儿高胆红素血症的临床疗效。方法:将120例新生儿高胆红素血症的病人随机分为治疗组和对照组各60例,两组均采用酶诱导剂、蓝光照射及其他综合治疗,治疗组加用妈咪爱,比较两组血清总胆红素下降情况。结果:治疗组血清总胆红素下降明显高于对照组(P<0.01)。结论:妈咪爱用于治疗新生儿高胆红素血症,可迅速降低血胆红素水平,安全有效,可作为治疗新生儿高胆红素血症的方法之一。
Objective: To investigate the clinical efficacy of probiotics in the treatment of neonatal hyperbilirubinemia. Methods: 120 cases of neonatal hyperbilirubinemia patients were randomly divided into treatment group and control group of 60 cases, both groups were treated with enzyme inducer, blue light and other comprehensive treatment, the treatment group with Mommy love, Serum total bilirubin levels were compared between the two groups. Results: The serum total bilirubin in treatment group was significantly lower than that in control group (P <0.01). Conclusion: Mommy love for the treatment of neonatal hyperbilirubinemia, can quickly reduce the level of serum bilirubin, safe and effective, as one of the ways to treat neonatal hyperbilirubinemia.